Improving Ventilatory Capacity in Those With Chronic High Level SCI
About this trial
The purpose of this study is to find out if the drug Buspar increases breathing capacity in individuals with chronic, high-level spinal cord injuries. Buspar is already approved and in clinical use to treat anxiety disorders. In earlier studies, Buspar was shown to improve breathing function in disorders other than SCI. This study focuses on breathing function during exercise. If included in the study, participants will randomly be assigned to one of two study groups: either taking Buspar pills and performing exercises; or taking placebo pills and performing exercises. Final testing, including breathing function, will be performed after 14 days.
Included participants
Traumatic
Non-traumatic
What’s involved
Type
Details
- Taking Buspirone (Buspar) or placebo pills orally for 14 days
Potential benefits
Main benefits
General health
Additional benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Recruiting
- Trial start date
- 29 Nov 2020
- Organisation
- Spaulding Rehabilitation Hospital
- Trial recruitment status
- Recruiting
- Trial start date
- 29 Nov 2020
- Organisation
- Spaulding Rehabilitation Hospital
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more